33rd Annual European Pharma Congress

About Conference

The most anticipated Pharma event in the world and you're invited to attend 33^rd Annual European Pharma Congress scheduled during March 13-14, 2023 at Frankfurt, Germany. which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions! This strategic conference will provide in-depth presentations and interactive sessions, for the possibility to network with like-minded professionals and discuss how to overcome the current challenges in pharmaceutical product synthesis and product development. The focus this year will be on the latest advancements, research and development to inspect the challenges in Pharmaceutical Sciences, Clinical Research and related areas. Pharma Europe 2023 is a specially designed cluster of all European Pharma conferences. The main theme of this Pharma conference is “Challenges and Advancements in Pharmaceutical Sciences ” which covers a wide range of critically important sessions. At Pharma Europe 2023 meet your target audiences from around the world focused on learning about Pharma and Pharma regulations, licenses, approvals. This conference would be your single best opportunity to reach the largest assemblage of participants from the Pharma field

Conference Highlights

Track 1: Pharmaceutical Sciences

The Pharmaceutical sciences combine broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies. Pharmaceutical Sciences is a dynamic and interdisciplinary field that aims to integrate fundamental principles of physical and organic chemistry, engineering, biochemistry, and biology to understand how to optimize delivery of drugs to the body and translate this integrated understanding into new and improved therapies against human disease. At the many of institutes internationally recognized faculty contribute to the field through inquiry into the underlying mechanisms of drug interactions with the human body and development of advanced synthetic or biologically-derived materials that can modulate these interactions in pursuit of better and safer therapies and drug products. The worldwide market for pharmaceutical science instruments and reagents came to $47.8 billion in 2012. This figure is relied upon to increment to $51.3 billion in 2013 and $77.6 billion in 2018, with an anticipated five-year compound yearly development rate (CAGR) of 8.6%.

22^ndInternational Conference on Medicinal and Pharmaceutical Chemistry March 21-22, 2023 Vancouver, Canada; International Conference on Biosimilars & Pharmaceuticals June 23-24, 2023 Paris, France ; 15^th International Conference & Expo on Chromatography Techniques January 30-31, 2023 Barcelona, Spain ; 24^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems January 30-31, 2023 Barcelona, Spain; 16th European Biosimilars Congress April 03-04, 2023 Barcelona, Spain

Related Societies:

Societies in USA: American Society of Pharmacognosy (ASP), Phytochemical Society of North America (PSNA), The Herb Society of America, American Herbal Products Association (AHPA)

Societies in Europe: Phytochemical Society of Europe (PSE), Society for Medicinal Plant and Natural Product Research, European Herbal and Traditional Medicines Association (EHTPA)

Societies in Asia and Pacific: The Asian Society of Pharmacognosy (ASP), Society of Pharmacognosy, Malaysian Natural Product Society (MNPS), The Japanese Society of Pharmacognosy, Australian Society of Plant Scientists

Track 2: Pharmaceutical Chemistry

Pharmaceutical chemistry is the study of drugs, and it involves drug development. This includes drug discovery, delivery, absorption, metabolism, and more. There are elements of biomedical analysis, pharmacology, pharmacokinetics, and pharmacodynamics. Pharmaceutical chemistry work is usually done in a lab setting. The chemical industry is one of the world’s largest branches and has significant influence on many other industries. Total global chemical shipments are worth an enormous five billion U.S. dollars.

Related Societies:

Societies in USA: American College of Clinical Pharmacology, American Society for Clinical Pharmacology and Therapeutics, American Neurological Association (ANA), American Society of Neuroimaging, American Board of Psychiatry and Neurology (ABPN), American Academy of Neurology (AAN)Societies in Europe: The Federation of European Pharmacological Societies, The European Association for Clinical Pharmacology and Therapeutics (EACPT), The European Behavioural Pharmacology Society (EBPS), British Pharmacological Society

Societies in Asia and Pacific: Korean Society of Pharmacology, Malaysian Society of Pharmacology and Physiology (MSPP), Pharmacological Society of Taiwan, Japanese Pharmacological Society

Track 3: Drug Regulations

Drugs and Regulations are very important in aspects of Pharmaceutical sciences where it deals with Drug safety, Cost effectiveness, Drug rediscovery, Pharmaceutical services, Role of pharmacists, Radio Pharmaceuticals and Multiple drug use etc. The regulation of drugs varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level or at both state and national levels by various bodies, as is the case in Australia.

Related Societies:

Societies in USA: Accreditation Council for Pharmacy Education, American Institute of the History of Pharmacy, American Society of Health-System Pharmacists, American Society of Consultant Pharmacists(ASCP)

Societies in Europe: European Medicines Agency, Federal Agency for Medicines and Health Products (FAGG), Danish Health and Medicines Authority (SST), Bulgarian Drug Agency (BDA), Federal Institute for Drugs and Medical Devices (BfArM), National Organization for Medicines (EOF)

Societies in Asia and Pacific: China Food and Drug Administration (CFDA), Drug Office - Department of Health, Pharmaceuticals and Medical Devices Agency (PMDA), Ministry of Food and Drug Safety (MFDS), Pharmacy and Drug Control

Track 5: Pharmaceutical Formulations

Pharmaceutical formulations, in pharmaceutics, are the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule.

Related Societies:

Societies in USA: American Coatings Association, Parenteral Drug Association (PDA), American Association of Pharmaceutical Scientists (AAPS), Consumer Healthcare Products Association, American Urological Association (AUA), Pharmacy Society of Wisconsin (PSW),

Societies in Europe: Pharmaceutical Society of New Zealand Incorporated (PSNZI), Royal Pharmaceutical Society (RPS), Association of British Pharmaceutical Industry (ABPI)

Societies in Asia and Pacific: Bangladesh Pharmaceutical Society (BPS), Society for Pharmaceutical Dissolution Science (SPDC), Pharmaceutical and Bioscience Society (PBS)

Track 6: Pharmaceutical Nanotechnology

Sometimes called, molecular manufacturing is a branch of engineering that deals with the design and manufacture of extremely small electronic circuits and mechanical devices built at the molecular level of matter. Nanotechnology is also being applied to or developed for application to a variety of industrial and purification processes. Purification and environmental clean-up applications include the desalination of water, water filtration, wastewater treatment, groundwater treatment, and other Nano remediation.

The global market for nanotechnology dots was estimated to generate $121.0 million in revenues in 2013. This market is expected to reach about $1.1 billion in 2016 and about $3.1 billion by 2018, at a compound annual growth rate (CAGR) of 90.8% for the five-year period, 2013 to 2018.

Related Societies:

Societies in USA: American Nano Society: Nanotechnology Community, American Academy of Nano Medicine, International Association of Nanotechnology, Microscopy Society of America, American Bar Association Section Nanotechnology Project, American Chemical Society - Nanotechnology Safety Resources.

Societies in Europe: European Nanoscience and Nanotechnology Association, European Nano Technology Gateway, British Society for Nano Medicine, Scottish Center for Nano Technology in Construction Materials, British Society for Nanomedicine.

Societies in Asia and Pacific: Asia Nano Forum, Asian Nanoscience And Nanotechnology Association

Track 7: Drug Delivery Systems

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues.

Related Societies:

Societies in USA: Controlled Release Society, Society for Biomaterials, American Chemical Society, American Coatings Association, Parenteral Drug Association, American Association of Pharmaceutical Scientists (AAPS)

Societies in Europe: The British Society for Nanomedicine, European Society for Biomaterials, Royal Pharmaceutical Society of Great Britain, Turkish Pharmacists Association

Societies in Asia and Pacific: Pharmaceutical Society of Korea, Pharmaceutical Society of Australia, Pharmacy Guild of Australia

Track 8: Pharmaceutical Formulation

The drug discovery starts with Pre-formulation Studies which is initiated by Disease Identification then carried onto suitable drug identification then after Stability Analysis of Drug, Behavioural Analysis, Dissolution, High Performance Liquid Chromatography or Nuclear Magnetic Resonance (NMR) as per the ICH guidelines.

The global market for Pre-formulation studies that is for the drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019

Related Societies:

Societies in Europe: The British Society for Nanomedicine, European Society for Biomaterials, Royal Pharmaceutical Society of Great Britain, Turkish Pharmacists Association

Societies in Asia and Pacific: Pharmaceutical Society of Korea, Pharmaceutical Society of Australia, Pharmacy Guild of Australia

Track 9: Pharmaceutics

Pharmaceutics plays an important role in drug discovery like drug disposition, Innovations in clinical development, Pharmaceutical technology, Pharmaceutics and drug delivery, Drug design, Targeted drug, gene delivery, Sustained drug delivery system, Routes of administration, Fundamental drug development.

The global market for quantum dots (QDs) was estimated to generate $121 million in revenues in 2013. This market is expected to reach about $1.1 billion in 2016 and about $3.1 billion by 2018, at a compound annual growth rate (CAGR) of 90.8% for the five-year period, 2013 to 2018.

Related Societies:

Societies in USA: American Statistical Association, Controlled Release Society, Society for Biomaterials, American Chemical Society, American Coatings Association, Parenteral Drug Association, American Association of Pharmaceutical Scientists (AAPS), Parenteral Drug Association (PDA), The International Society of Biopharmaceutical Statistics.

Societies in Europe: European Biopharmaceutical Enterprises, The Danish Society for Biopharmaceutical Statistics, European Society for Biomaterials, Royal Pharmaceutical Society of Great Britain, Turkish Pharmacists Association

Societies in Asia and Pacific: Chinese Biopharmaceutical Association, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, Chinese American Biopharmaceutical Society.

Track 10: Pharmaceutical Engineering

Pharmaceutical engineering is a branch of engineering focused on discovering, formulating, and manufacturing medication, as well as analytical and quality control processes. It utilizes the fields of chemical engineering, biomedical engineering, and Pharmaceutical sciences.

The global genetic engineering market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%. Increased RandD expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019).

Related Societies:

Societies in USA: American Society of Gene Therapy, Biotechnology and Biological Research Council, Genetics Society of America, The American Society of Human Genetics, Center for Genetics and Society, National Society of Genetic Counselors, American Society for Cell Biology.

Societies in Europe: European Society of Human Genetics, European Peptide Society, European Federation of Biotechnology, European Association of Pharma Biotechnology, German Resource Centre for Genome Research, European federation of biotechnology https://europe.pharmaceuticalconferences.com/registration.php

Societies in Asia and Pacific: Asia Pacific Society of Human Genetics, Asia-Pacific Society of Eye Genetics, Asia Pacific Society of Human Genetics, Genetics Society of Thailand.

Track 11: Pharmaceutical Microbiology

Pharmaceutical Microbiology is involves in the study of microorganisms associated with the manufacture of pharmaceuticals e.g. minimizing the number of microorganisms and is a specialist area of microbiology and one concerned with the use of microorganisms in pharmaceutical development and with maintaining contamination control.

Related Societies:

Societies in USA: US Radiopharmaceuticals, NCM USA, Avid Radiopharmaceuticals, Inc, Society of Nuclear Medicine and Molecular Imaging (SNMMI), American College of Nuclear Medicine (ACNM), American Society of Nuclear Cardiology

Societies in Europe: European Association of Nuclear Medicine, Society of Radiopharmaceutical Sciences, British Nuclear Medicine Society, Society of Nuclear Medicine.

Societies in Asia and Pacific: Asia Pacific Society for Materials Research, Nuclear Medicine Society(Singapore), Society of Nuclear Medicine India, Asia and Oceania Federation of Nuclear Medicine and Biology(AOFNMB).

Track 12: Pharma Companies

Pharma Companies in Europe - Kowa Pharmaceutical, Aegerion Pharmaceuticals Ltd, Kent Pharmaceuticals, Alan Pharmaceuticals, Alliance Pharmaceutical Limited. Pharmaceutical Companies are knowledge driven industry and is heavily dependent on Research and Development for new products and growth. However, basic research discovering of new molecules is a time consuming and expensive process and is thus, dominated by large global multinationals.

Related Societies:

Societies in Asia and Pacific: Chinese Biopharmaceutical Association, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, Chinese American Biopharmaceutical Society

Track 13: Clinical Pharmacy

Clinical pharmacy is the branch of pharmacy in which clinical pharmacists provide direct patient care that optimizes the use of medication and promotes health, wellness, and disease prevention.

Clinical Pharmacy is a unique service provided by the leading pharmacy departments in the United States. The concept of Clinical Pharmacy evolved after the significant increase in number of pharmaceuticals in the market and the increasing potential of drug interactions.

Related Societies:

Societies in USA: American Society of Health-System Pharmacists, American Pharmacists Association, South Carolina Society of Health-System Pharmacists, Oregon Society of Health Systems Pharmacists, Massachusetts Society of Health-System Pharmacists, Canadian Pharmacists Association

Societies in Europe: The Federation of European Pharmacological Societies, European Association of Employed Community Pharmacists in Europe (EPhEU), European Pharmaceutical Union (EPU), Pharmaceutical Group of the European Union (PGEU), Danish Association of Pharma Economists.

Societies in Asia and Pacific: Chinese Pharmaceutical Association, Indian Pharmacist Association, Kuwait Pharmaceutical Association, Pharmaceutical Association of Mauritius.

Track 14: Industrial Pharmacy

Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.

The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. The United States alone holds some 40 percent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars. Many of the global top companies are located in the United States. In 2014, six out of the top eleven companies were U.S.-based.

Related Societies:

Societies in USA: Industry Pharmacists Organization, American Pharmacists Association, American Association of Pharmaceutical Scientists (AAPS), American Statistical Association, Controlled Release Society, Society for Biomaterials, American Chemical Society, American Coatings Association, Parenteral Drug Association, American Association of Pharmaceutical Scientists (AAPS), Parenteral Drug Association (PDA), The International Society of Biopharmaceutical Statistics.

Societies in Asia and Pacific: Chinese Biopharmaceutical Association, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, Chinese American Biopharmaceutical Society.

Track 15: Pharmaceutical Biotechnology

Pharmaceutical biotechnology is a relatively new and growing field in which the principles of biotechnology are applied to the development of drugs. A majority of therapeutic drugs in the current market are bioformulations, such as antibodies, nucleic acid products and vaccines.

Related Societies:

Societies in USA: National Association of Pharmacy Regulatory Authorities, Regulatory Affairs Professionals Society (RAPS), Regulatory Affairs - American Chemical Society, The Organisation for Professionals in Regulatory Affairs; Regulatory Affairs North America, Society of Quality Assurance

Societies in Europe: European Society of Regulatory Affairs, Legal and Regulatory Affairs Committee

Societies in Asia and Pacific: Regulatory Affairs Professionals Society Singapore, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, Chinese American Biopharmaceutical Society.

Track 16: Pharmaceutical Nanotechnology

Nanomedicine is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition. In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit. Drugs may lead to side-effects due to poor delivery at the actual site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused. Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.

Related Societies:

Societies in USA: American Academy of Nanomedicine, Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nano Medicine International Association of Nanotechnology and Graphene Stakeholders Association

Societies in Europe: Nanotechnology Industries Association, Royal Microscopical Society, Royal Society - Nanotechnology and Nanoscience, British Society for Nanomedicine, European Society for Nanomedicine, French Society for Nanomedicine, European Nano Business Association, European Society for Precision Engineering and Nanotechnology, Czech Nanotechnology Industries Association and Erwin Schrödinger Society for Nano sciences

Societies in Asia: National Center for Nanoscience and Technology, Indian Society for Nanomedicine, Nano Technology Research Association and Indian Society of Nanomedicine.

Track 17: Pharmacy Development Services

Pharmacy Development Services offers independent pharmacy owners profit-generating strategies in operations, business development, data analytics, and many more .The Pharma consultants work with organizations of all sizes including academic institutes, start-up companies, and established organizations. The services aims to increase the patient’s knowledge of their medication and improve their adherence to the regimen. Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion from which Germany provides ready access to internationally renowned scientists, world-class research and pharmaceuticals markets.

Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion from which Germany provides ready access to internationally renowned scientists, world-class research and pharmaceuticals markets.

Related Societies:

Societies in Asia and Pacific: Chinese Biopharmaceutical Association, Pharmaceutical Society of Australia, Pharmacy Guild of Australia, Chinese American Biopharmaceutical Society.

Special Issues

All accepted abstracts will be published in respective International Journals.

Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: http://europe.pharmaceuticalconferences.com/

33^rd Annual European Pharma Congress

Menu

Tuesday 25 October 2022

Pharma Europe 2022

About Conference

Conference Highlights

Special Issues